Lord, Abbett & Co’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-409,127
| Closed | -$22.9M | – | 586 |
|
|
2023
Q4 | $22.9M | Sell |
409,127
-365,959
| -47% | -$20.5M | 0.08% | 317 |
|
|
2023
Q3 | $32M | Sell |
775,086
-481,240
| -38% | -$19.9M | 0.12% | 240 |
|
|
2023
Q2 | $70.2M | Buy |
1,256,326
+206,237
| +20% | +$11.5M | 0.24% | 126 |
|
|
2023
Q1 | $58.6M | Buy |
+1,050,089
| New | +$58.6M | 0.21% | 156 |
|
|
2022
Q2 | – | Sell |
-59,159
| Closed | -$4.5M | – | 629 |
|
|
2022
Q1 | $4.5M | Sell |
59,159
-26,483
| -31% | -$2.01M | 0.01% | 555 |
|
|
2021
Q4 | $12.8M | Buy |
85,642
+36,403
| +74% | +$5.42M | 0.03% | 453 |
|
|
2021
Q3 | $7.17M | Buy |
49,239
+7,891
| +19% | +$1.15M | 0.02% | 562 |
|
|
2021
Q2 | $8.1M | Sell |
41,348
-320,798
| -89% | -$62.8M | 0.02% | 563 |
|
|
2021
Q1 | $65.5M | Sell |
362,146
-216,080
| -37% | -$39.1M | 0.17% | 193 |
|
|
2020
Q4 | $81.9M | Buy |
578,226
+81,421
| +16% | +$11.5M | 0.22% | 140 |
|
|
2020
Q3 | $61.9M | Sell |
496,805
-31,298
| -6% | -$3.9M | 0.2% | 160 |
|
|
2020
Q2 | $47.2M | Sell |
528,103
-260,988
| -33% | -$23.3M | 0.17% | 199 |
|
|
2020
Q1 | $49.2M | Buy |
789,091
+135,256
| +21% | +$8.43M | 0.22% | 139 |
|
|
2019
Q4 | $49.9M | Sell |
653,835
-79,289
| -11% | -$6.05M | 0.17% | 186 |
|
|
2019
Q3 | $36.9M | Buy |
+733,124
| New | +$36.9M | 0.13% | 277 |
|